Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Voted
Yes it’s been a whole month. Plan failed, shut the company down. Lmao.
What kind of upgrade? They put out an upgrade to buy on the 14th of November. Analysts upgrades would be very short lived price wise anyways in this market, execute the vision, don’t leave it to analysts.
The volume is super light, incredibly easy to manipulate in that environment. Picked up shares at $16.70 for what should be a pretty profitable trade on the quick rebound. This shit happens all the time.
I think that’s exactly what people are expecting in tomorrow’s script numbers. The fact the offering was placed in placed in under an hour speaks very well of investor confidence.
That’s because medicaid is the lowest of any payer but Medicare can actually be pretty decent.
I think you got a decent amount of information we have not heard before in this chat, which was very good. Too many people are playing CEO here when they really have no clue what is happening. If you trusted JT before then trust him and the team now. I’ve been through partnerships and many M&A deals, the outside world is wrong about almost everything they think they know typically.
At this point I agree, you can’t just rehashing the same information. Some new information has to come out. Without tipping his hand completely, JT should be offering more insight
Yep but this drop is on very light volume. Expect it won’t last
Not much to do with amarin. The market overall is very negative as the tariffs extension was not good news that people were really hoping for.
Make it 200% return. Hate Monday mornings. Still don’t BO is the way the company is going though.
Less than a month ago TSRO traded all the way down to $25 a share. Speculation of buyout seemed to be helping drive price back up but 300% from very recent low isn’t too shabby. Amrn was similarly pushed down hard and is still recovering price.
The talk is getting crazy and so is any idea the FDA would ever attempt to take Vascepa off the market. For some reason biotechs tend to bring out all these outlandish projection and statements.
Yeah they were prescheduled sales as part of a bigger stock sale plan the executives have in place.
Looks like we are back up and running. Hopefully Sam will post scripts here soon as well. Seemed to be excellent numbers
Thanks Sam, this is what I was looking for.
Yes someone here a few days ago posted a good trend analysis of the change in each of the last few years, from the week before thanksgiving to that week. That’s about the only comparison to me that can be made, to prior years change results. I think the numbers overall were something like a 13% reduction on average. I’ll see if I can find the post.
I think we all know what you are doing.
Because the options can be sold at any time it’s highly unlikely this is a bet that the stock will collapse under $5.00, but a option strategy of buying way out of the money options in hope of a continuing major downtrend. A move down to say the $12-$13 area again quickly would push the premium about 3-4 times the current premium price.
That would be true if they were buying European options, but they didn’t.
You don’t know they are taking their sweet time. Honestly the people on this board don’t know anything about what is happening inside the company but everyone seems to think they do. Management didn’t suddenly become clueless.
Yep we will fill that pretty soon I believe. My accounts at least hopes so..lol. In long run, the cash will help much more than the small dilution. Happy to hold for a while.
For the technicians any gap on the chart in the low 16s is now closed
For the technicians any gap on the chart in the low 16s is now closed
They are momentum traders. It is done on the long and short side and it’s not illegal, so nothing can be done.
Myself I have add both stock under 17 and $17 March 15th calls. Amarin has now become my largest holding, but when people panic for flawed reasons, I will do what I think is take advantage. In a few days think we run right back up to $19
They were looking for something that was likely never coming from it
$18.00 was the price set and that is where we are trading. For the moment, seems appropriate.
Debt payments are part of the cash flow calculation, that’s the only tie in
Hope that’s accurate. Something damn sure brought buyers in about $17.80, so I bought a good chunk for trading there. If that’s accurate, this will rebound.
If it’s that low of shares, that’s not bad at all. My guess is more like 25 million.
Thanks. Yeah that will hammer the stock price, especially because we don’t know the size of the offering.
Is this actually real? The site listed seems like a hoax
Ah I got you and I see what you mean. The problem sometimes especially with options is that the devil is in the details and the more you understand those inner workings, the less likely you are to make mistakes. No sure STS will ever be using options, but they are far from the evil instrument some think they are, just too many people go for home runs, much like biotech stocks I guess.
Damn hate autocorrect. It’s a BASIC term in options, not better term.
Since when did intrinsic value become
fancy terminology? It is a better term in options. And your example still leaves out the remaining time which would make the option worth more than your numbers.
STS, what you aren’t seeing is the 2nd part of how options are priced. You are citing the intrinsic value of the option, but you are missing the time value, which is the 2nd component. Take for example, I bought $16 calls at $3.75 with a March 15, 2019 expiration. The current price of those options is about $6.00. The intrinsic value portion is the 20% the stock is up over $16, however the overall option is up 60% because the other portion of 40% is the value assigned to the time value. Option will return much greater returns than straight stock purchases but can also be worthless, hence the risk and increased reward.
AF, I’m not sure what the volume down in the $14’s has to do with a return to there, that’s really not how stocks trade. The volume there was manufactured by a legal firm announcing an investigation and a panic selling that had set in from many weak hands buying for the AHA.
If this stock hits $23 and collapses to $14 again something would have to be monumentally wrong. There will be some profit taking, but with the increase in scripts, there will be new buyers getting on board.
Most technicians I’ve ever worked with consider that gap closed on the charts.
Between script growth and a Europe deal, the shorts just don’t have the same power the 2nd time around, which is why you are seeing higher lows. Once AMRN reaches the $20’s again I think you will see a slow choppy drift up towards $25 by year end, unless something big gets announced. Just don’t see year end selling as a big issue here given the stock price.
The script numbers will concern shorts and planned bear attacks, a Europe deal announcement scares the shit out of them
Yep we figure this one out. It looked like it was written to be 2 different strikes but one was actually the date